June 21, 2011
The KU School of Medicine–Wichita is seeking participants for a
study that will offer cutting-edge treatment to individuals in Wichita and south central Kansas suffering from treatment-resistant major depression.
The KU School of Medicine–Wichita is one of only 10 sites across the country to conduct this initial study. “Treatment-resistant major depression is a serious illness from the patients’, their
families’, and society’s perspective,” said Sheldon Preskorn, MD, an investigator for the study.
Depression is the leading cause of disability in the United States and is projected to be the leading cause of disability worldwide by 2015-2020 by the World Health Organization.
The KU School of Medicine–Wichita is currently seeking patients who have not benefitted adequately from their current antidepressant treatment.
Participants must be between 18 and 65 years old. The study will consist of four visits, including one 24-hour inpatient stay at the KU Wichita Clinical Trial Unit in Wichita.
Participants will be compensated for their time.
Those interested in learning more about the study may call (316) 293-1821 or e-mail email@example.com.